Scientific Review Board

Members from two different advisory groups, the Scientific Review Board and the Business Review Board, review all grant applications submitted to the ADDF. The Scientific Review Board is composed of over 150 scientists who encompass various areas of expertise within Alzheimer’s research.

  • Stephen Friend, MD, PhD
    Sage Bionetworks

  • Douglas R. Galasko, MD
    University of California, San Diego

  • Samuel Gandy, MD, PhD
    Mount Sinai School of Medicine

  • Hugo Geerts, PhD
    In Silico Biosciences, Inc.

  • Ezio Giacobini, MD, PhD
    Geneva University Hospitals

  • Paul Gilligan, PhD
    Pennsylvania Drug Discovery Institute

  • Marcie A. Glicksman, PhD
    Harvard Neurodiscovery Center

  • Todd E. Golde, MD, PhD
    Mayo Clinic

  • Jennifer Goldman, MD, MS
    Rush University Medical Center

  • Gunnar K. Gouras, MD
    Weill Medical College of Cornell University

  • Illana Gozes, PhD
    Tel Aviv University

  • Allan M. Green, MD, PhD, JD
    Allan M. Green Esq., LLC

  • Barry D. Greenberg, PhD
    University Health Network

  • Francine Grodstein, ScD
    Brigham and Women's Hospital

  • John Hardy, PhD
    UCL Institute of Neurology